Sunrise Looking To International Markets For Hyperion LTK Hyperopia System
This article was originally published in The Gray Sheet
Executive Summary
Sunrise Technologies is looking toward international market opportunities for its Hyperion laser thermal keratoplasty (LTK) ophthalmic Holmium laser system following a July 22 "not approvable" recommendation for treatment of hyperopia from FDA's Ophthalmic Devices Panel (1"The Gray Sheet" July 26, p. 3).